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Abstract
Background: Although chronic kidney disease (CKD) disproportionately affects older adults, they are less likely to
be referred to a nephrologist. Factors that influence the referral decisions of primary care providers (PCPs)
specifically for older CKD patients have been incompletely described. Patient factors such as dementia, functional
disability, and co-morbidity may complicate the decision to refer an older adult. This study evaluated the role of
patient and PCP factors in the referral decisions for older adults with stage 4 CKD.
Methods: We administered a two-part survey to study the decisions of practicing PCPs. First, using a blocked
factorial design, vignettes systematically varied 6 patient characteristics: age, race, gender, co-morbidity, functional
status, and cognitive status. CKD severity, patient preferences, and degree of anemia were held constant. Second,
covariates from a standard questionnaire included PCP estimates of life expectancy, demographics, reaction to
clinical uncertainty, and risk aversion. The main outcome was the decision to refer to the nephrologist. Random
effects logistic regression models tested independent associations of predictor variables with the referral decision.
Results: More than half (62.5%) of all PCP decisions (n = 680) were to refer to a nephrologist. Vignette-based factors
that independently decreased referral included older patient age (OR = 0.27; 95% CI, 0.15 to 0.48) and having moderate
dementia (OR = 0.14; 95%CI, 0.07 to 0.25). There were no associations between co-morbidity or impaired functional
activity with the referral decision. Survey-based PCP factors that significantly increased the referral likelihood include
female gender (OR = 7.75; 95%CI, 2.07 to 28.93), non-white race (OR = 30.29; 95%CI, 1.30 to 703.73), those who expect
nephrologists to discuss goals of care (OR = 53.13; 95%CI, 2.42 to 1168.00), those with higher levels of anxiety about
uncertainty (OR = 1.28; 95%CI, 1.04 to 1.57), and those with greater risk aversion (OR = 3.39; 95%CI, 1.02 to 11.24).
Conclusions: In this decision making study using hypothetical clinical vignettes, we found that the PCP decision to
refer older patients with severe CKD to a nephrologist reflects a complex interplay between patient and provider
factors. Age, dementia, and several provider characteristics weighed more heavily than co-morbidity and functional
status in PCP referral decisions. These results suggest that practice guidelines should develop a more nuanced
approach to the referral of older adults with CKD.
Background
Chronic kidney disease (CKD) is a recognized public
health concern that preferentially affects older adults,
more than a third of whom over age 70 meet the formal
definition of CKD [1,2]. According to current Kidney
Disease Outcomes Quality Initiative (KDOQI) guide-
lines, patients with severe CKD (a glomerular filtration
rate (GFR) of less than 30 ml/min/1.73 m
2) should be
referred to a nephrologist to manage the potential com-
plications of CKD, slow the progression to end stage
kidney disease, prepare patients for renal replacement
therapy, and reduce mortality [3-5]. However, older
adults though more likely to have severe CKD, are less
likely to be referred to a nephrologist [5-7]. Previous
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providers suggest that more severe kidney disease,
increased complexity of medical co-morbidity, limited
life expectancy and patient preferences against dialysis,
in addition to older age, influence provider referral deci-
sions [8-11]. Our own work suggests that providers also
consider the cognitive and functional status of older
patients when deciding whether or not to refer the
patient to a nephrologist [12]. In addition to patient fac-
tors, PCP characteristics might explain some of the
variability in referral decisions [11,13]. However, pre-
cisely how PCPs prioritize and incorporate these patient
factors into their decision-making strategy when addres-
sing individual patients is not known. We previously
outlined a conceptual framework that describes the
complexity of PCP referral decisions for CKD and incor-
porates three main components relevant to the referral
decision: patient characteristics, provider characteristics,
and disease characteristics [14,15]. This study was
designed to systematically assess the role of specific
patient characteristics while accounting for characteris-
tics of practicing PCPs that might influence referral
decisions for older adults with severe CKD.
Methods
Study Design
We developed an online survey with two components:
1) a series of hypothetical clinical vignettes specifically
designed to evaluate the independent effect of selected
patient factors on the PCP decision to refer older
patients with CKD and 2) a survey questionnaire to
evaluate provider and practice characteristics, reaction
to clinical uncertainty, and risk aversion.
The clinical vignettes were randomly assigned by using a
blocked factorial design which varied 6 patient characteris-
tics across each vignette: age, race, gender, medical co-
morbidity, functional status, and cognitive status. These
factors were chosen based on prior work that indicated
that the presence of geriatric co-morbidities might be
important in provider decisions to refer older adults with
advanced CKD [12]. Each patient characteristic was
defined as follows: 1) age as either “young old” age 67 or
“old old” age 80; 2) gender as male or female; 3) race as
black or white; 4) co-morbidity as the presence or absence
of New York Heart Association class III congestive heart
failure [16]; 5) functional status as ambulation with a
walker or without assistive device; and 6) cognitive status
as the presence or absence of moderate dementia [17].
The blocked factorial design allows for identification
of the independent associations for each individual
patient factor (as well as for 2-factor interactions) by
dichotomously varying each patient factor creating a
total of 64 (2
6) unique vignettes. The blocked factorial
design limits respondent burden by reducing the
number of vignettes each PCP received while retaining
the randomized assignment of 6 selected patient charac-
teristics [18]. Each provider answered a randomly
assigned block of 8 vignettes [18] (Table 1).
We held other important patient factors constant for
each vignette. Patients were described as having no
strong preferences about referral and would defer to
PCP decision. All patients had completed 12
th grade and
had outpatient visit insurance coverage. All patients had
well-controlled hypertension and diabetes, mild anemia
(hemoglobin level of 11.5 mg/dL), and a GFR equal to
20 ml/min/1.73 m
2, a level of renal function at which
referral to the nephrologist is recommended [3].
Covariates
Survey-based factors were assessed using a questionnaire
previously tested in a pilot study, including previously-
validated instruments [12]. Covariates included PCP
demographic and practice information, disease-specific
knowledge, attention to patient characteristics, experi-
ence with older CKD patients, expectations of the
nephrology referral, risk aversion, and level of clinical
uncertainty. PCPs’ personal and practice demographic
information included age, gender, race/ethnicity, foreign
medical school graduate status, primary specialty, and
community of practice (urban or non-urban). PCPs
reported whether they were aware of existing KDOQI
guidelines for management of CKD [3]. PCPs rated the
importance of patient characteristics (patient age, race,
medical co-morbidities, functional status, cognitive sta-
tus, and the severity of CKD) in the decision to refer to a
nephrologist. PCPs estimated the percentage of adults
over age 65 in their practice, the number of referrals to
nephrology they made in the last year, and the remaining
life expectancy for each vignette patient. Potential PCP
expectations of a nephrology referral were for: 1) blood
pressure management; 2) treatment of anemia with ery-
thropoietin: 3) discussion of CKD prognosis; 4) discus-
sion about dialysis initiation; and 5) discussion of goals of
care. PCP level of clinical uncertainty was evaluated
using the validated Physician Reaction to Uncertainty
Scale comprised of subscales for anxiety about uncer-
tainty, concern about bad outcomes, reluctance to dis-
close uncertainty to patients, and reluctance to disclose
uncertainty to other providers [19]. PCP level of risk
aversion was assessed using a general question about risk
taking behavior: “compared to other people your age,
would you say you are": less willing to take risks, equally
willing to take risks, or more willing to take risks.
Outcomes
The primary outcome was whether the provider would
recommend referral of the vignette patient to the
nephrologist (yes or no).
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Participants were a purposeful sample of two commu-
nity-based PCP provider groups who were active mem-
bers of two Practice-based Regional Networks (PBRNs):
the Upstate New York Network (UNYNET) based in
Buffalo, New York and the Oklahoma Practice Research
Network (OKPRN) based in Oklahoma City, Oklahoma.
Network members were invited to participate in the sur-
vey because of their interest in CKD and because of
their prior experience participating in online surveys
[20]. The study was approved by the Institutional
Review Boards of the Biological Sciences Division at the
University of Chicago and the University of Oklahoma
Health Sciences Center; and exempted at the State Uni-
versity of New York at Buffalo.
Survey Administration and Recruitment
A total of 204 PCPs were invited to participate in the
survey via email by the network director and provided
informed consent. PCPs were sent follow-up emails
every other week for 6 weeks. PCPs in the OKPRN who
did not respond to email invitations after 6 weeks
received a phone call and were mailed a written version
of the survey. PCPs in the UNYNET who submitted the
survey were given a $20 gift certificate to an online
bookstore. PCPs in the OKPRN collectively chose to
accept a payment of $1000 to the network general
research fund rather than receive individual payments.
Data Analysis
All analyses were conducted based on PCP responses to
each vignette and accounted for clustering at the level
of the provider. Bivariate analyses of patient and provi-
der characteristics were evaluated by Spearman correla-
tion, Wilcoxon-rank sum, chi-square or paired t-tests as
appropriate. Sequential, random effects, multivariate
logistic regression models were used to test the indepen-
dent association of patient characteristics (Model 1),
provider demographics (Model 2), and other provider
characteristics including experience, expectations, dis-
ease-specific knowledge, risk aversion and uncertainty
preferences (Model 3) with the decision to refer. Each
model had new variables added as a block. All analyses
were performed using STATA software version 11 (Col-
lege Station, TX).
Results
Eighty-five PCPs responded to the survey yielding a 42%
response rate similar to that of other studies [2,9].
R e s p o n d e n t sw e r eo v e r w h e l m i n g l ym a l e( 7 7 . 6 % ) ,w h i t e
(90.2%), family practice physicians (89.3%), and the
majority practiced in an urban setting (61.2%) (Table 2).
The demographic characteristics of respondents were
not statistically significantly different from those of non-
responders (data not shown). The PBRNs were similar
except in the report of awareness and use of KDOQI
practice guidelines, which was significantly higher in the
UNYNET group (100% versus 69.7%, p = 0.01). The vast
majority of providers (87.1%) reported that the vignettes
were “somewhat” or “very representative” of patients
they see in their own practice.
Collectively, the respondent PCPs made 680 referral
decisions. Despite all vignette patients being appropriate
for referral based on KDOQI guideline recommenda-
tions, PCPs did not recommend referral in 257 (37.8%)
of their decisions. PCPs most commonly cited multiple
medical co-morbidities, no intervention warranted, and
medical management that can be done in the PCP’s
office as reasons for non-referral.
T h em a j o r i t yo fP C P sr e p o r t e dt h a tt h es e v e r i t yo f
CKD was a “moderately” or “very important” factor in
their decision to refer (69.5%). A much smaller group of
Table 1 Example of random block of clinical vignettes provided to PCP respondents
Vignette
1
67 year old white male with history of diabetes, hypertension, and NYHA class III heart failure has chronic kidney disease with a GFR
of 20 for greater than 3 months. He is ambulatory without assistive device. He has no history of dementia.
Vignette
2
80 year old black male with history of diabetes and hypertension has chronic kidney disease with a GFR of 20 for greater than 3
months. He is ambulatory without assistive devices. He has no history of dementia.
Vignette
3
67 year old white female with history of diabetes and hypertension has chronic kidney disease with a GFR of 20 for greater than 3
months. She is ambulatory but requires use of a walker. She has no history of dementia.
Vignette
4
80 year old black female with history of diabetes, hypertension, and NYHA class III heart failure has chronic kidney disease with a GFR
of 20 for greater than 3 months. She is ambulatory but requires use of a walker. She has no history of dementia.
Vignette
5
80 year old white female with history of diabetes, hypertension, and NYHA class III heart failure has chronic kidney disease with a
GFR of 20 for greater than 3 months. She is ambulatory without assistive device. She has history of moderate dementia (MMSE 15).
Vignette
6
67 year old black male with history of diabetes, hypertension, and NYHA class III heart failure has chronic kidney disease with a GFR
of 20 for greater than 3 months. He is ambulatory but requires use of a walker. He has history of moderate dementia (MMSE 15).
Vignette
7
67 year old black female with history of diabetes and hypertension has chronic kidney disease with a GFR of 20 for greater than 3
months. She is ambulatory without assistive device. She has history of moderate dementia (MMSE 15).
Vignette
8
80 year old white male with history of diabetes and hypertension has chronic kidney disease with a GFR of 20 for greater than 3
months. He is ambulatory but requires use of a walker. He has history of moderate dementia (MMSE 15).
Bolded items represent patient characteristics that were systematically varied.
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status (32.9%) and the presence and severity of addi-
tional co-morbidities (45.9%) were at least “moderately”
important in their referral decision. Only a few PCPs
reported that patient age (16.5%) or race (3.5%) played
an important role in their referral decision.
PCPs overwhelmingly expected nephrologists to evalu-
ate the etiology of CKD (97%), discuss prognosis (98%),
discuss the initiation of dialysis (94.1%), and discuss
goals of care (96%) with referred patients. Most of them
expected the nephrologist to manage CKD-associated
anemia (64%), but not the blood pressure (40%).
Bivariate Analyses
Patient factors
In bivariate analyses, older patient age (44.7% referred ver-
sus 58.8% non-referred, p < 0.001) and the presence of
moderate dementia (41.4% versus 68.1%, p = 0.01) were
strongly associated with a decision not to refer (Table 3).
Other patient factors (and 2-factor interactions) were not
statistically significantly associated with the referral decision
including functional disability, as demonstrated by impaired
ambulation requiring a walker (49.2% versus 51.4%, p =
0.58), and the presence of an additional serious co-morbid-
ity, i.e., class III CHF, (50.1% versus 49.8%, p = 0.94).
PCP factors
PCP mean estimated remaining life expectancy was sig-
nificantly different between referred and non-referred
patients (6.11 ± 3.53 versus 5.38 ± 4.15, p = 0.02). PCP
demographic characteristics of female gender (27.9%
versus 13.2%, p < 0.001) and non-white race (13.2% ver-
sus 4.1%, p < 0.001) were strongly associated with a
decision to refer. PBRN affiliation (75.4% versus 84.4%,
p < 0.001), urban practice setting (64.3% versus 56.0%, p
= 0.03) and foreign medical school graduate status
(13.7% versus 12.5%, p = 0.03) also were associated with
the decision to refer (Table 3).
PCP rating of the importance of patient age (13.7 versus
21.0%, p = 0.01) and cognitive status (26.0 versus 44.3%, p
= < 0.001) were associated with non-referral while rating
the severity of CKD as more important was associated
with referral (76.0 versus 57.6%, p < 0.001) (Table 3). PCP
report of having referred more than 10 patients to
nephrology in the previous year was associated with a
decision to refer (52.0 versus 32.7%, p < 0.001) while hav-
ing greater percentage of older patients in PCP practice
(0.27 ± 0.44 versus 0.37 ± 0.48, p = 0.01) was associated
with non-referral. PCP expectation of nephrologists to
evaluate the etiology of CKD (63.0% versus 37.0%, p =
0.01) and discuss goals of care (63.4% versus 36.5%, p =
0.001) were associated with a decision to refer. PCP anxi-
ety about uncertainty (16.75 ± 4.20 versus 16.11 ± 3.78, p
= 0.04) and risk aversion (77.8% versus 68.1%, p = 0.01)
were the only PCP attributes that were significantly asso-
ciated with the decision to refer in the bivariate analysis.
Multivariate logistic regression analyses
In random effects, multivariate logistic regression mod-
els, older patient age (OR = 0.27; 95%CI, 0.15 to 0.48)
and the presence of dementia (OR = 0.14; 95%CI, 0.07
to 0.25) remained independently associated with lower
likelihood of referral in the fully-adjusted model (Table
4). Longer estimated remaining life expectancy was not
independently associated with the referral decision (OR
= 0.99; 95%CI, 0.90 to 1.09).
Provider demographics, such as non-white race (OR =
30.29; 95%CI, 1.30 to 703.73) and female gender (OR =
7.75; 95%CI, 2.07 to 28.93), PCP report of the importance
of CKD severity (OR = 17.43; 95%CI, 4.90 to 61.93) and
greater numbers of referrals in the past year (OR = 4.21;
95%CI, 1.54 to 11.48) were associated with higher likeli-
hood of referral. PCP expectation of nephrologist to dis-
cuss goals of care was also associated with higher
likelihood of referral (OR = 53.13; 95%CI, 2.42 to 1168.00).
PCP attributes including higher levels of anxiety about
uncertainty (OR = 1.28; 95%CI, 1.04 to 1.57) and greater
risk aversion (OR = 3.39; 95%CI, 1.02 to 11.24) were inde-
pendently associated with the decision to refer. PCP
Table 2 Demographics of primary care provider respondents
Overall
(n = 85)
UNYNET
(n = 18)
OKPRN
(n = 67)
P value
Age, mean (SD) 49.9 (9.7) 49.1 (8.9) 50.1 (9.8) 0.78
Female, (%) 22.4 27.8 20.9 0.53
Non-White, (%) 9.8 16.7 7.8 0.26
Family Practice Specialty, (%) 89.3 88.9 89.9 0.72
Urban Practice Setting, (%) 61.2 72.2 58.2 0.28
Estimated percentage of practice over age 65, mean (SD) 17(20) 3 (16.7) 14 (20.9) 0.25
Estimated number of patients referred to nephrology last year, mean (SD) 38 (44.7) 9 (50.1) 29 (43.2) 0.61
Self-reported awareness of Kidney Disease Outcomes Quality Initiative guidelines, (%) 76.2 100 69.7 0.01*
Vignettes “somewhat” or “very representative” of patients in practice, (%) 87.1 94.4 85.1 0.29
*Values reaching level of significance p < 0.05
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likelihood of referral (OR = 0.81; 95%CI, 0.67 to 0.97).
Discussion
CKD is an important health concern for older adults
and yet they do not access nephrology services at the
same rates as younger patients with equivalent severity
of disease. In this study of PCP decision making about
nephrology referral for hypothetical patients with severe
CKD, we find that nearly 1/3 of older patients are not
referred despite meeting guideline criteria for referral.
We identified that older age and moderate dementia
Table 3 Bivariate analysis of referred versus not referred vignette patients (n = 680 decisions)
Referred
(n = 423)
Not Referred
(n = 257)
P value
Patient Characteristics
Older Age, (%) 44.7 58.8 < 0.001*
Female gender, (%) 50.4 49.2 0.81
Black race, (%) 51.3 47.9 0.38
Presence of stage III CHF, (%) 50.1 49.8 0.94
Ambulation with walker, (%) 49.2 51.4 0.58
Presence of moderate dementia, (%) 41.4 68.1 0.01*
PCP Demographics
Older Age, mean (SD) 50.3 (9.89) 49.2 (9.26) 0.14
Non-white race, (%) 13.2 4.1 < 0.001*
Female gender, (%) 27.9 13.2 < 0.001*
OKPRN, (%) 75.4 84.4 0.01*
Urban practice, (%) 64.3 56.0 0.03*
Foreign Medical School Graduate, (%) 13.7 12.5 0.03*
PCP Experience
Estimation of Remaining Life Expectancy, mean (SD) 6.11 (3.53) 5.38 (4.15) 0.02*
Report of knowledge of KDOQI guidelines, (%) 75.7 77.11 0.67
Importance of Patient Age, (%) 13.71 21.01 0.01*
Importance of Patient Race, (%) 4.73 1.56 0.03*
Importance of Co-morbidities, (%) 46.81 44.36 0.53
28.13 31.52 0.35
Importance of Patient Cognitive Status, (%) 26.00 44.36 < 0.001*
Importance of Severity of CKD, (%) 76.60 57.59 < 0.001*
Estimated proportion of patients over age 65, mean (SD) 0.27 (0.44) 0.37 (0.48) 0.01*
More than 10 patients referred to nephrology in last 1 year, (%) 52.01 32.73 < 0.001*
PCP Expectations
Expectation that nephrologist would evaluate etiology of CKD, (%) 63.00 37.00 0.01*
Expectation that nephrologist would manage blood pressure, (%) 63.29 36.67 0.65
Expectation that nephrologist would treat anemia, (%) 62.34 37.71 0.96
Expectation that nephrologist would discuss prognosis, (%) 62.19 37.83 0.98
Expectation that nephrologist would discuss initiation of dialysis, (%) 62.10 38.02 0.49
Expectation that nephrologist would discuss goals of care, (%) 63.40 36.60 0.001*
PCP Reaction to Uncertainty and Risk Aversion
Anxiety about uncertainty
†, mean (SD) 16.75 (4.20) 16.11 (3.78) 0.04*
Concern about bad outcomes
‡, mean (SD) 8.84 (3.55) 8.40 (3.66) 0.12
Reluctance to disclose uncertainty to patients
§, mean (SD) 17.47 (3.99) 17.85 (3.19) 0.20
Reluctance to disclose uncertainty to other providers
¢, mean (SD) 4.54 (2.14) 4.45 (1.57) 0.54
Risk aversion, n (%) 77.8 68.1 0.01*
* Values reaching significance level p < 0.05; The Physician Reaction to Uncertainty Scale subscale ranges are
†6-30 points,
‡ 3-18 points,
§ 6-30 points, and
¢ 2-12
points
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Model 1
OR
(95% CI)
P value Model 2
OR
(95% CI)
P value Model 3
OR
(95% CI)
P value
Patient Characteristic
Older Age 0.32
(0.20 to 0.51)
< 0.001* 0.28
(0.17 to 0.47)
< 0.001* 0.27
(0.15 to 0.48)
< 0.001*
Female gender 1.10
(0.70 to 1.72)
0.68 0.92
(0.57 to 1.46)
0.71 0.91
(0.55 to 1.50)
0.72
Black race 1.29
(0.83 to 2.03)
0.26 1.33
(0.83 to 2.12)
0.24 1.46
(0.89 to 2.41)
0.14
Presence of Stage III CHF 1.03
(0.66 to 1.61)
0.90 1.03
(0.65 to 1.64)
0.91 1.00
(0.60 to 1.68)
1.00
Ambulates with walker 0.83
(0.53 to 1.30)
0.42 0.85
(0.54 to1.36)
0.51 0.89
(0.54 to 1.46)
0.66
Presence of moderate dementia 0.16
(0.10 to 0.27)
< 0.001* 0.16
(0.09 to 0.27)
< 0.001* 0.14
(0.07 to 0.25)
< 0.001*
PCP Demographics
Older Age 1.04
(1.01 to 1.06)
< 0.001 1.03
(0.97 to 1.09)
0.29
Non-white race 3.65
(1.67 to 7.95)
0.001* 30.29
(1.30 to 703.73)
0.03*
Female gender 3.42
(2.11 to 5.58)
< 0.001* 7.75
(2.07 to 28.93)
0.002*
OKPRN 0.60
(0.38 to 0.93)
0.02 0.33
(0.06 to 1.87)
0.21
Urban practice 1.10
(0.77 to 1.59)
0.60 0.64
(0.24 to 1.710
0.38
Foreign Medical School Graduate 1.09
(0.71 to 1.67)
0.69 1.80
(0.33 to 9.78)
0.50
PCP Experience
Estimation of Remaining Life Expectancy 0.99
(0.90 to 1.09)
0.73
Report of knowledge of KDOQI guidelines 1.09
(0.30 to 3.98)
0.89
Importance of Patient Age 1.12
(0.20 to 6.23)
0.89
Importance of Patient Race 0.01
(0.00 to 0.31)
0.01
Importance of Patient Functional Status 1.28
(0.36 to 4.56)
0.70
Importance of Patient Cognitive Status 0.33
(0.08 to 1.25)
0.10
Importance of Severity of CKD 17.43
(4.90 to 61.93)
< 0.001*
Importance of Co-morbidities 0.22
(0.07 to 0.77)
0.02*
Majority of patients over age 65 1.07
(0.38 to 3.00)
0.89
More than 10 patients referred to nephrology in last 1 year 4.21
(1.54 to 11.48)
0.01*
PCP Expectations of Referral
Expectation that nephrologist would evaluate etiology of CKD 2.16
(0.14 to 32.82)
0.58
Expectation that nephrologist would manage blood pressure 0.92
(0.33 to 2.58)
0.88
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referred while other patient factors including medical
co-morbidity and functional disability do not impact
such decisions. We also find that the likelihood of refer-
ral is impacted by provider characteristics and expecta-
tions independent of patient factors. These results
suggest that referral decisions are complex in ways that
current practice guidelines do not address.
Our finding that a large number of hypothetical
patients with CKD are not referred to nephrology is
consistent with previous studies of actual patient popu-
lations. Previous studies suggest that 33-85% of persons
with moderate to severe CKD were unknown to
nephrology services [5,7]. In several retrospective studies
of CKD populations, older age is associated with lower
likelihood of referral [5,7,9]. Our study further confirms
that patient age is a strong predictor of non-referral.
However, our study also evaluated several other fac-
tors commonly associated with age to determine
whether PCPs use age alone or as a proxy for other age-
associated conditions. In our study, moderate dementia
is independently associated with a lower likelihood of
referral. Previous studies have not identified dementia as
an independent factor for non-referral. Perhaps this is
because dementia is under-recognized and under-diag-
nosed even in the CKD population where persons are at
higher risk [21,22]. Contrary to other studies about
CKD referral, medical co-morbidity is not associated
with the referral decision in this study [9]. This finding
may be a result of the study design in which we varied
the presence or absence of a single co-morbidity (stage
I I IC H F ) .T h ep r e s e n c eo fs t a g eI I IC H Fa l o n em a yn o t
influence the referral decision. Instead, provider referral
decisions might be more strongly influenced by other
significant co-morbidities [23]. Using this study design,
we did not have the sample size to fully account for all
the possible co-morbidities. Contrary to our previous
findings, functional disability was not associated with
the referral decision [12]. In these clinical scenarios,
functional disability was represented as the use of an
assistive device for ambulation. We hypothesized that
PCPs would view the use of a walker as an indication of
frailty and, therefore, they would be less likely to refer
[12]. However, providers may not identify functional dis-
ability or frailty by the presence of impaired ambulation.
Perhaps deficits in independent activities of daily living
(IADLs), which we did not assess, are more important
to providers. A fuller accounting of other relevant fac-
tors awaits future work.
PCP estimation of longer remaining life expectancy for
a patient was significantly associated with the decision
to refer in bivariate analyses although the difference was
less than 1 year and of unclear clinical significance.
However, estimated remaining life expectancy was not
independently associated with likelihood of referral in
multivariate analyses. Remaining life expectancy is a
concept that incorporates age, gender, number/severity
of medical co-morbidities, and the presence of func-
tional disability into an estimation of physiologic age
[24,25]. Arguably, remainingl i f ee x p e c t a n c yc o u l db e
Table 4 Multivariable analyses for the decision to refer vignette patients (n = 680 decisions) (Continued)
Expectation that nephrologist would treat anemia 0.28
(0.09 to 0.89)
0.03*
Expectation that nephrologist would discuss prognosis 0.20
(0.01 to 7.88)
0.39
Expectation that nephrologist would discuss initiation of dialysis 1.09
(0.10 to 12.40)
0.94
Expectation that nephrologist would discuss goals of care 53.13
(2.42 to 1168.00)
0.01*
PCP Risk and Uncertainty
Anxiety about uncertainty 1.28
(1.04 to 1.57)
0.02*
Concern about bad outcomes 0.81
(0.67 to .97)
0.03*
Reluctance to disclose uncertainty to patients 0.92
(0.72 to 1.18)
0.50
Reluctance to disclose uncertainty to other providers 0.95
(0.73 to 1.25)
0.73
Risk aversion 3.39
(1.02 to 11.24)
0.05*
Sequential, random effects, multivariate logistic regression models were used to test the independent association of patient characteristics (Model 1), provider
demographics (Model 2), and other provider characteristics including experience, expectations, disease-specific knowledge, risk aversion and uncertainty
preferences (Model 3) with the decision to refer. Each model had new variables added as a block.
* Values significant to p < 0.05
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cant heterogeneity of older adults where chronologic
age may not be as important for outcomes [25]. In this
study, PCPs exhibited significant variability in estimating
remaining life expectancy suggesting that across PCPs
there are inconsistencies in how providers calculate or
conceptualize life expectancy. These inconsistencies in
life expectancy calculations have important implications
for the possible use of life expectancy rather than age in
practice guidelines for CKD. If provider life expectancy
estimates are significantly inaccurate, then the decisions
made based on such estimates might be inappropriate.
Future decision making studies could address how pro-
viders estimate life expectancy and determine whether
providing an estimate of life expectancy would alter the
referral decision.
In comparison to the few patient factors which
affected the referral decision, we found several PCP fac-
tors that were statistically associated with the decision.
Although several of these PCP factors have wide confi-
dence intervals suggesting imprecise estimates due to
the sample size, the potential implications of their influ-
ence on provider decision making should be further
examined in future studies. The greater the importance
of CKD severity to the PCP, the more likely he or she is
to refer the patient, suggesting that raising PCP aware-
ness about the health consequences of CKD might
impact referral decisions. Also, PCPs who report refer-
ring greater numbers of patients to nephrology in the
preceding year were more likely to refer the hypothetical
patients. PCP expectation that the nephrologist would
discuss goals of care, but not dialysis initiation, was very
strongly associated with a higher likelihood of referral.
Perhaps PCPs are reluctant or unprepared to discuss
care goals with older patients who have severe CKD.
This finding suggests that PCPs expect nephrologists to
engage patients in a broader discussion about goals and
not simply discuss dialysis. Interestingly, we find that
PCP gender and race are independently associated with
referral consistent with previous studies of referral beha-
vior in other contexts [26-28]. It is unclear why this
gender and race difference occurs. Our analyses are
adjusted for PCP age, awareness of guidelines, reaction
to uncertainty, and risk aversion, which might be
hypothesized to vary by gender and race. While some of
these factors exerted their own independent effects on
the referral decision, they did not attenuate the effect of
provider gender and race. Specifically, we find that PCP
anxiety about clinical uncertainty, concern about bad
outcomes, and greater risk aversion have significant
independent effects on the referral decision. These
results do suggest a potential role for these provider
characteristics in decision making. The full meaning of
the associations of these general measures of clinical
uncertainty and risk aversion on referral decisions man-
agement of CKD awaits future work.
We hypothesize that PCP factors including expecta-
tions, personality traits, and risk preferences are impor-
tant in decision making when the outcome of the
decision is uncertain. In the case of referral to the
nephrologist for severe CKD, PCPs confront several
uncertainties including: 1) how likely is this older
patient with CKD to progress to end-stage renal disease;
2) will the patient have strong preferences about starting
dialysis if it is indicated; or 3) will the referral to
nephrology result in improved outcomes for this indivi-
dual patient. Given the lack of evidence to answer these
uncertainties, it is likely that PCP characteristics, expec-
tations, and personality traits will be more important in
the decision making and contribute to practice variation.
As evidence accumulates to address these uncertainties
and guidelines incorporate this evidence into algorithms
for risk assessment of older adults, the effects of these
PCP characteristics on the referral decision may dimin-
ish. It remains to be seen if CKD-focused educational
efforts targeting PCPs would eliminate the gender and
race discrepancies or reduce the effect of personality
traits in referral decision making.
There are several limitations to this study. First, this is
a study of decision making using hypothetical vignettes.
Decision making studies that involve clinical vignettes
are highly correlated with decisions made during actual
patient encounters; and vignettes are a cost-effective
means of evaluating decisions that may not be easily
studied in routine practice [29,30]. In this study, the
careful control over variables of interest (e.g. GFR) pro-
vides insight into the specific role of the selected patient
factors in the referral decision, but somewhat limits
inferences for actual practice. Specifically, the effect of
other medical co-morbidities associated with CKD, but
not included in this study, on the referral decision was
not assessed. Future studies involving actual patients
would be needed to supplement this work and help to
determine if these patient factors, or other disease-speci-
fic factors such as malnutrition or hypoalbuminemia,
influence referral practices. Second, this is a study of a
relatively small group of PCPs in practice-based research
networks. As such, these results may not generalize to
PCPs in other settings. However, this study did involve
community-based PCPs from different types of practices
and settings, in 2 different regions of the country. These
findings are similar to results of our previous study of
internists, geriatricians, and nephrologists at an aca-
demic institution [12,23]. The lower response in this
study is comparable to other physician surveys and is
typical of internet-based studies [2,9]. A larger, more
representative sample of practicing providers would be
needed to further test these findings. Third, through the
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CKD and patient preferences, both of which may be
important in the PCP’s decision to refer the patient.
Future studies could vary GFR to determine if providers
use a threshold level of GFR to decide whether to refer
regardless of other factors and whether this threshold
differs from current guideline recommendations. We
also recognize that patient (and family) preferences are
important. The assumption that patients have no strong
preferences about referral to a nephrologist may be
incorrect. Perhaps patients (and families) equate a refer-
ral to nephrology with a decision about initiating dialy-
sis. If this is true, then educating patients and PCPs
about the important role of the nephrologist in mana-
ging severe CKD might improve referral rates. Addi-
tional studies are needed to understand patient
expectations of a nephrology referral.
Conclusions
Our findings provide new insight into PCP referral deci-
sions for older adults with severe CKD to the nephrolo-
gist. In this study of PCP decision making using
hypothetical clinical vignettes to systematically vary spe-
cific patient factors, we identify previously unrecognized
patient (e.g. cognitive impairment) and provider (e.g.
risk preferences) factors which independently predict
which older patients with severe CKD are more likely to
be referred by PCPs to a nephrologist. Additional work
is necessary to determine if geriatric conditions like cog-
nitive impairment and provider characteristics are also
important in the outcomes of older patients with
advanced CKD. Still, the results of this study underscore
the complexity of the referral decision where a see-
mingly simple clinical recommendation–to refer an
older adult with severe CKD as guidelines recommend–
may involve challenging tradeoffs among multiple
factors.
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